The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | Unmet needs for late-stage CTCL
Maarten Vermeer, MD, PhD, Leiden University Medical Center, Leiden, Netherlands, talks on unmet medical needs in cutaneous T-cell lymphoma, highlighting the need for more efficacious therapies and improvements to prognostication for late-stage disease. Dr Vermeer also discusses the identification of novel drug targets and the potential benefits of recently approved therapies. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
